{
    "clinical_study": {
        "@rank": "62142", 
        "arm_group": {
            "arm_group_label": "Ablation", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to collect preliminary safety and effectiveness data evaluating\n      the Toray Satake Balloon Thermal Ablation System (TSB)to treat subjects with symptomatic\n      paroxysmal atrial fibrillation that is resistant to antiarrhythmic drug therapy."
        }, 
        "brief_title": "Pilot Study Evaluating the Toray Satake Balloon Thermal Ablation System for Treatment of Paroxysmal Atrial Fibrillation", 
        "condition": "Paroxysmal Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of recurrent symptomatic paroxysmal atrial fibrillation\n\n          -  \u22652 Symptomatic atrial fibrillation episodes\n\n          -  At least 1 paroxysmal atrial fibrillation episode documented by an ECG or device\n             recording system in the 6 months prior to enrollment AND\n\n          -  At least 1 additional (for a total of \u22652) paroxysmal atrial fibrillation episode\n             documented by an ECG or device recording system, OR, at a minimum, a physician's note\n             indicating recurrent symptomatic atrial fibrillation\n\n          -  No episode >7 days\n\n          -  Failed to respond to or is intolerant of \u22651 Class I, II, III or IV antiarrhythmic\n             drug\n\n          -  Able and willing to provide informed consent and Health Insurance Privacy and\n             Portability Act (HIPAA) authorization\n\n          -  Able and willing to meet all study requirements, including attending all\n             post-ablation procedure assessments and visits\n\n        Exclusion Criteria:\n\n          -  Left atrium \u226550 mm\n\n          -  Chronically used amiodarone in the 3 months prior to enrollment\n\n          -  Previous left atrial ablation or surgical treatment for atrial fibrillation\n\n          -  Left ventricular ejection fraction (LVEF) <35 %\n\n          -  New York Heart Association (NYHA) Class III or IV heart failure\n\n          -  History of myocardial infarction (MI) or unstable angina in the 6 months prior to\n             enrollment\n\n          -  Multiple other exclusion criteria to establish overall good health and likely study\n             compliance"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "35", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01997736", 
            "org_study_id": "Toray America 2013-001"
        }, 
        "intervention": {
            "arm_group_label": "Ablation", 
            "intervention_name": "Ablation", 
            "intervention_type": "Device", 
            "other_name": "Toray Satake Balloon Thermal Ablation System"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Paroxysmal Atrial Fibrillation", 
            "Catheter Ablation", 
            "Ablation Techniques"
        ], 
        "lastchanged_date": "March 5, 2014", 
        "location": [
            {
                "contact": {
                    "email": "jwegner@beaumonthospitals.com", 
                    "last_name": "James H Wegner, BS", 
                    "phone": "248-898-3123"
                }, 
                "facility": {
                    "address": {
                        "city": "Royal Oak", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48073"
                    }, 
                    "name": "William Beaumont Hospital, Royal Oak"
                }, 
                "investigator": {
                    "last_name": "David Haines, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "betsy.ellsworth@mountsinai.org", 
                    "last_name": "Betsy A. Ellsworth, MSN, ANP", 
                    "phone": "212-824-8902"
                }, 
                "contact_backup": {
                    "email": "mindy.lopez@mountsinai.org", 
                    "last_name": "Mindy Lopez", 
                    "phone": "212-824-8925"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "Mount Sinai Hospital"
                }, 
                "investigator": {
                    "last_name": "Vivek Reddy, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Pilot Study Evaluating the Safety and Effectiveness of the Toray Satake Balloon Thermal Ablation System for the Treatment of Paroxysmal Atrial Fibrillation", 
        "overall_official": {
            "affiliation": "William Beaumont Hospitals", 
            "last_name": "David Haines, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Occurrence of major complications", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "reference": [
            {
                "PMID": "12875422", 
                "citation": "Satake S, Tanaka K, Saito S, Tanaka S, Sohara H, Hiroe Y, Miyashita Y, Takahashi S, Murakami M, Watanabe Y. Usefulness of a new radiofrequency thermal balloon catheter for pulmonary vein isolation: a new device for treatment of atrial fibrillation. J Cardiovasc Electrophysiol. 2003 Jun;14(6):609-15."
            }, 
            {
                "citation": "Sohara H, Satake S, Tanaka K, et al. Modification of electrophysiological properties of pulmonary veins and adjacent left atrial tissue by radiofrequency thermal balloon circumferential ablation around the pulmonary vein ostia: correlation with non-recurrence of atrial fibrillation. Journal of Arrhythmia 21(3):384-397, 2005."
            }, 
            {
                "PMID": "19808472", 
                "citation": "Sohara H, Takeda H, Ueno H, Oda T, Satake S. Feasibility of the radiofrequency hot balloon catheter for isolation of the posterior left atrium and pulmonary veins for the treatment of atrial fibrillation. Circ Arrhythm Electrophysiol. 2009 Jun;2(3):225-32. doi: 10.1161/CIRCEP.108.817205. Epub 2009 Apr 2."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01997736"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Toray Industries (America), Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Toray Industries (America), Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}